Brandinium

Trademark search for:

DELTA DIABETES EXCHANGE: LEARNING THROUGH AWARENESS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2013-07-10 — Application filed
  • 2013-07-13 — Application filed
  • 2013-07-18 — Application filed
  • 2013-07-19 — Notice of design search code e-mailed
  • 2013-10-16 — Assigned to examiner
  • 2013-10-23 — Final disposition recorded
  • 2013-10-23 — Final disposition recorded
  • 2013-10-23 — Final disposition recorded
  • 2014-03-18 — Attorney/dom.rep.revoked and/or appointed
  • 2014-03-18 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-03-19 — Automatic update of assignment of ownership
  • 2014-05-21 — Application abandoned
  • 2014-05-21 — Application abandoned
  • 2014-05-21 — Final status recorded
  • 2014-10-08 — Assignment of ownership not updated automatically

Owner Information

ASTRAZENECA AB
SODERTALJE SE
Bristol-Myers Squibb Company
New York , NY

Correspondent

Marc Stanislawczyk AstraZeneca Pharmaceuticals LLP
1800 Concord Pike
FOP3-022
Wilmington, DE 19850-5437

Filing Details

Filing Date:
2013-07-10
Status Date:
2014-05-21
Category:
Science & Technology Services
Filing Year:
2013

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.